tiprankstipranks
Advertisement
Advertisement
MediWound Earnings Call: Promise Amid Near-Term Strain
PremiumCompany AnnouncementsMediWound Earnings Call: Promise Amid Near-Term Strain
2M ago
MediWound Q1 2026 Results Highlight EscharEx Trial Progress and BARDA Boost for NexoBrid
Premium
Company Announcements
MediWound Q1 2026 Results Highlight EscharEx Trial Progress and BARDA Boost for NexoBrid
2M ago
MediWound reports Q1 EPS (23c), consensus (66c)
Premium
The Fly
MediWound reports Q1 EPS (23c), consensus (66c)
2M ago
MediWound Highlights Vericel’s $197 Million BARDA Contract for NexoBrid
PremiumCompany AnnouncementsMediWound Highlights Vericel’s $197 Million BARDA Contract for NexoBrid
4M ago
MediWound says Vericel awarded ten-year contract valued at up to $197M
Premium
The Fly
MediWound says Vericel awarded ten-year contract valued at up to $197M
4M ago
MediWound Sets May 6, 2026 Shareholder Meeting to Vote on Board, Auditor and CEO Bonus
Premium
Company Announcements
MediWound Sets May 6, 2026 Shareholder Meeting to Vote on Board, Auditor and CEO Bonus
4M ago
Buy Rating Backed by Temporary Q4 Disruption, Long-Term Government Contracts, and NexoBrid-Driven Growth
PremiumRatingsBuy Rating Backed by Temporary Q4 Disruption, Long-Term Government Contracts, and NexoBrid-Driven Growth
4M ago
MediWound Posts 2025 Loss but Strengthens Cash and Advances EscharEx, NexoBrid Capacity
Premium
Company Announcements
MediWound Posts 2025 Loss but Strengthens Cash and Advances EscharEx, NexoBrid Capacity
5M ago
MediWound reports Q4 EPS (56c), consensus (61c)
Premium
The Fly
MediWound reports Q4 EPS (56c), consensus (61c)
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100